AstraZeneca PLC (AZN) vs Marvell Technology, Inc. (MRVL)
AZN leads on 13 of 17 compared metrics.
A side-by-side comparison of AstraZeneca PLC and Marvell Technology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — AZN vs MRVL
growth of $100 · last 26yAZN +302.8%MRVL +1875.3%MRVL compounded faster
AZN MRVL
AZN vs MRVL: by the numbers
- •AZN is the larger company ($277.22B vs $244.68B market cap).
- •AZN trades at the lower earnings multiple (26.92 vs 96.16 P/E).
- •MRVL converts more revenue to profit (28.99% vs 17.19% net margin).
- •MRVL grew revenue faster over the past five years (22.90% vs 16.99% CAGR).
- •AZN pays the higher dividend yield (1.79% vs 0.09%).
Which is better, AZN or MRVL?
Metric tally: AZN 13 · MRVL 4It depends on what you're optimizing for:
ValueAZN(lower P/E)
GrowthMRVL(faster 5Y revenue CAGR)
IncomeAZN(higher dividend yield)
QualityAZN(higher ROIC)
Metrics side by side
Valuation
| Metric | AZN | MRVL |
|---|---|---|
| P/E ratio | 26.92● | 96.16 |
| Forward P/E | 15.33● | 45.59 |
| P/S ratio | 4.62● | 28.66 |
| P/B ratio | 5.90● | 13.72 |
| PEG ratio | 0.14● | 21.37 |
| EV / EBITDA | 14.92● | 54.41 |
| FCF yield | 2.89%● | 0.67% |
Profitability
| Metric | AZN | MRVL |
|---|---|---|
| Gross margin | 81.68%● | 50.64% |
| Operating margin | 23.69%● | 16.20% |
| Net margin | 17.19% | 28.99%● |
| ROE | 21.95%● | 13.87% |
| ROIC | 13.03%● | 5.98% |
Dividends
| Metric | AZN | MRVL |
|---|---|---|
| Dividend yield | 1.79%● | 0.09% |
| Payout ratio | 48.48% | 7.74% |
Growth (annualized)
| Metric | AZN | MRVL |
|---|---|---|
| Revenue CAGR (5Y) | 16.99% | 22.90%● |
| EPS CAGR (5Y) | 22.02%● | 4.50% |
| FCF CAGR (5Y) | 15.68% | 26.05%● |
| Total return CAGR (5Y) | 11.03% | 40.47%● |
Frequently asked
- Which is better, AZN or MRVL?
- It depends on your goal. value: AZN (lower P/E); growth: MRVL (faster 5Y revenue CAGR); income: AZN (higher dividend yield); quality: AZN (higher ROIC). Across all compared metrics, AZN leads 13 to 4.
- Is AZN or MRVL cheaper?
- On trailing earnings, AZN is cheaper: AZN trades at a 26.92 P/E and MRVL at 96.16.
- Which has grown faster, AZN or MRVL?
- Over the past five years, MRVL grew revenue faster — AZN at a 16.99% CAGR versus MRVL at 22.90%.
- Does AZN or MRVL pay a bigger dividend?
- AZN yields 1.79% and MRVL yields 0.09% based on trailing dividends and the latest price.
- Is AZN or MRVL more profitable?
- MRVL runs the higher net margin — AZN at 17.19% versus MRVL at 28.99%.
- Which has been the better investment, AZN or MRVL?
- Over the past 10-year, MRVL delivered the higher annualized total return — AZN at 15.77% versus MRVL at 40.79%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioMarvell Technology P/E ratioAstraZeneca dividend yieldMarvell Technology dividend yieldAstraZeneca ROEMarvell Technology ROEAstraZeneca operating marginMarvell Technology operating marginAstraZeneca revenue growthMarvell Technology revenue growthAstraZeneca free cash flowMarvell Technology free cash flow
AstraZeneca & Marvell Technology appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.